ClariTrial | Search Clinical Trials

Explore/Breast Cancer

Status

Phase

18,591 results for “Breast Cancer”

Page 1 of 1240

UNKNOWN

Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone Metastases

N/ABreast Neoplasm FemaleNeoplasm MetastasisSpinal Neoplasms

Overcome

Universidad de Granada58 participants1 site · SpainCompletes Jun 2024

Compare CT.gov Full analysis →

Terminated

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Phase 1Phase 2HER2-positive Breast CancerBreast Cancer Metastatic

Palbociclib 75mgLetrozole 2.5mgT-DM1+3 more

University of Kansas Medical Center3 participants5 sites · United StatesCompletes Mar 2020

Compare CT.gov Full analysis →

Recruiting

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Phase 2Breast Cancer

Disitamab Vedotin InjectionPertuzumab InjectionToripalimab

RemeGen Co., Ltd.40 participants1 site · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

UNKNOWN

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

N/ABreast Cancer

omega-3 fatty acid

Cedars-Sinai Medical Center80 participants1 site · United States

Compare CT.gov Full analysis →

Completed

Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery

N/ABreast Cancer

Radiation

University Hospital, Ghent488 participants1 site · BelgiumCompletes Jun 2023

Compare CT.gov Full analysis →

Active

Lymphovenous Anastomosis for Breast Cancer Lymphedema

N/ALymphedemaLymphedema ArmBreast Cancer Lymphedema

Lymphovenous anastomosis (LVA)

Odense University Hospital47 participants1 site · DenmarkCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

N/AEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma

Biospecimen CollectionTissue Collection

Mayo Clinic324 participants3 sites · United StatesCompletes May 2027

Compare CT.gov Full analysis →

Completed

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

N/ABreast CancerAdherence, MedicationSide Effect

BETA-Text text messaging intervention

Yale University400 participants1 site · United StatesCompletes Apr 2023

Compare CT.gov Full analysis →

Completed

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Phase 1Cancer

filgrastimcarboplatincisplatin+6 more

City of Hope Medical Center33 participants1 site · United StatesCompletes Aug 2015

Compare CT.gov Full analysis →

Completed

Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy

Phase 4Postoperative Pain

LidocaineRemifentanil

Hospital de Base60 participantsCompletes Aug 2014

Compare CT.gov Full analysis →

Recruiting

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3Breast Cancer

BracketingNeoadjuvant therapyPost-treatment volume margin resection+1 more

Mansoura University370 participants1 site · EgyptCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer

N/ABreast Cancer

propofol groupsevoflurane group

Konkuk University Medical Center218 participants1 site · South KoreaCompletes Dec 2016

Compare CT.gov Full analysis →

Completed

CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]

Phase 1Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult VolunteersBreast Cancer

Orialpha (BD-C)

Oriplantee Company Limited15 participants1 site · VietnamCompletes Jun 2025

Compare CT.gov Full analysis →

Terminated

Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment

N/ABreast Cancer SurvivorPregnant WomenQuality of Lifte

Questionnaire

M.D. Anderson Cancer Center30 participants1 site · United StatesCompletes Apr 2026

Compare CT.gov Full analysis →

Completed

Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives

N/AGenetic PredispositionBRCA MutationBreast Cancer

Histopathological confirmation

Aga Khan University Hospital, Pakistan26 participants1 site · PakistanCompletes Mar 2023

Compare CT.gov Full analysis →

1–15 of 18,591

Explore/Breast Cancer

Status

Phase

18,591 results for “Breast Cancer”

Page 1 of 1240

UNKNOWN

Overcome, a Program of Therapeutic Exercise and Functional Recovery to Improve the Functional Capacity of Women With Breast Cancer and Bone Metastases

N/ABreast Neoplasm FemaleNeoplasm MetastasisSpinal Neoplasms

Overcome

Universidad de Granada58 participants1 site · SpainCompletes Jun 2024

Compare CT.gov Full analysis →

Terminated

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Phase 1Phase 2HER2-positive Breast CancerBreast Cancer Metastatic

Palbociclib 75mgLetrozole 2.5mgT-DM1+3 more

University of Kansas Medical Center3 participants5 sites · United StatesCompletes Mar 2020

Compare CT.gov Full analysis →

Recruiting

DV in Combination With Pertuzumab With or Without Toripalimab Neoadjuvant Therapy With HER2-positive Breast Cancer

Phase 2Breast Cancer

Disitamab Vedotin InjectionPertuzumab InjectionToripalimab

RemeGen Co., Ltd.40 participants1 site · ChinaCompletes Jun 2026

Compare CT.gov Full analysis →

UNKNOWN

Omega-3 Fatty Acids in Preventing Breast Cancer in Women at High Risk of Developing Breast Cancer

N/ABreast Cancer

omega-3 fatty acid

Cedars-Sinai Medical Center80 participants1 site · United States

Compare CT.gov Full analysis →

Completed

Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery

N/ABreast Cancer

Radiation

University Hospital, Ghent488 participants1 site · BelgiumCompletes Jun 2023

Compare CT.gov Full analysis →

Active

Lymphovenous Anastomosis for Breast Cancer Lymphedema

N/ALymphedemaLymphedema ArmBreast Cancer Lymphedema

Lymphovenous anastomosis (LVA)

Odense University Hospital47 participants1 site · DenmarkCompletes Jun 2026

Compare CT.gov Full analysis →

Recruiting

Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform

N/AEarly Stage Triple-Negative Breast CarcinomaMetastatic Bladder Urothelial CarcinomaMetastatic Cervical Carcinoma

Biospecimen CollectionTissue Collection

Mayo Clinic324 participants3 sites · United StatesCompletes May 2027

Compare CT.gov Full analysis →

Completed

Text Messaging in Patients on Adjuvant Endocrine Therapy for Breast Cancer

N/ABreast CancerAdherence, MedicationSide Effect

BETA-Text text messaging intervention

Yale University400 participants1 site · United StatesCompletes Apr 2023

Compare CT.gov Full analysis →

Completed

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Phase 1Cancer

filgrastimcarboplatincisplatin+6 more

City of Hope Medical Center33 participants1 site · United StatesCompletes Aug 2015

Compare CT.gov Full analysis →

Completed

Effect of Intravenous Infusion of Lidocaine and Remifentanil Perioperatively in Patients Undergoing Mastectomy

Phase 4Postoperative Pain

LidocaineRemifentanil

Hospital de Base60 participantsCompletes Aug 2014

Compare CT.gov Full analysis →

Recruiting

Wide Margin vs. Narrow Margin in Postneoadjuvant Lumpectomy

Phase 3Breast Cancer

BracketingNeoadjuvant therapyPost-treatment volume margin resection+1 more

Mansoura University370 participants1 site · EgyptCompletes Aug 2026

Compare CT.gov Full analysis →

Completed

Assessment of the Anesthetic Effect on the Activity of Immune Cell in Patient With Breast Cancer

N/ABreast Cancer

propofol groupsevoflurane group

Konkuk University Medical Center218 participants1 site · South KoreaCompletes Dec 2016

Compare CT.gov Full analysis →

Completed

CLINICAL RESEARCH PROTOCOL [A Phase I, Single-arm, Open-label, Dose-escalation Clinical Study to Evaluate the Safety and Tolerability of Orialpha (BD-C) in Healthy Adult Volunteers]

Phase 1Evaluate the Safety Profile and Tolerability of Orialpha in Healthy Adult VolunteersBreast Cancer

Orialpha (BD-C)

Oriplantee Company Limited15 participants1 site · VietnamCompletes Jun 2025

Compare CT.gov Full analysis →

Terminated

Quality of Life in Breast Cancer Survivors Who Were Pregnant During Their Cancer Treatment

N/ABreast Cancer SurvivorPregnant WomenQuality of Lifte

Questionnaire

M.D. Anderson Cancer Center30 participants1 site · United StatesCompletes Apr 2026

Compare CT.gov Full analysis →

Completed

Frequency of Occult Breast Cancer After Prophylactic Mastectomy Among High-Penetrance Breast Cancer Gene Positives

N/AGenetic PredispositionBRCA MutationBreast Cancer

Histopathological confirmation

Aga Khan University Hospital, Pakistan26 participants1 site · PakistanCompletes Mar 2023

Compare CT.gov Full analysis →

1–15 of 18,591